Astra Zeneca and Merck
Mapping the Tumor 2.0
MANCHESTER
2024
2024
-
Video
-
-
-
Items
Credits
| Client | Astra Zeneca, Gaithersberg |
| Client | Merck, Darmstadt |
| Advertising Agency | Havas Lynx, Manchester |
| Production Company | Lightfarm, Rio de Janerio |
| Chief Creative Officer | Alex Okada / Havas Lynx Group |
| Chief Executive Officer | Claire Knapp / Havas Lynx |
| Creative Director | Sam Sargent / Havas Lynx |
| Creative Director | Richard Hague / Havas Lynx |
| Chief Medical Officer | Vernon Bainton / Havas Lynx |
| Chief Strategy Officer | Andrew Gardner / Havas Lynx |
| Executive Creative Director | Chris Wellard / Havas Lynx |
| Senior Creative | Kate Philips / Havas Lynx |
| Junior Creative | Chris Will / Havas Lynx |
| Executive Producer | Jeff Corrin / Havas Lynx |
| Senior Planner | Mikey Weal / Havas Lynx |
| Account Director | Ellen Shaw / Havas Lynx |
| Account Manager | Alex Taylor / Havas Lynx |
| Medical Writer | Mairiosa Hall / Havas Lynx |
| Creative Director | John McPartland / Havas Lynx |
| Senior account Manager | Matt Digby / Havas Lynx |
| Medical Writer | Nur Pirbhai / Havas Lynx |
This 2024 Clio Health Silver winning entry titled 'Mapping the Tumor 2.0' was entered for Astra Zeneca and Merck by Havas Lynx , Manchester . The piece was submitted to the medium: Creative Use of Data (Pharmaceutical) within the entry type: Direct-to-Professionals - Unbranded and the category: Targeting. It consists of 1 video and 3 images.
Follow Us